Pictured Above: Achromatopsia clinical trial patient Annie Joiner. She’s seen the world throughout her life in black and white until a gene therapy clinical trial gave her a first glimpse of color. No one has looked at the colors on an iPhone with as much fascination as Annie Joiner has in the past couple of […]
OHSU’s Vollum Institute is a scientific powerhouse, home to some of the world’s top minds dedicated to basic neuroscience research – that critical first step in developing new treatments for neurological and psychiatric disorders. Thanks in part to significant philanthropy, one lab at the Vollum has been unusually prolific, and it’s paying off. Eric Gouaux, […]
“Our covenant with patients is to use philanthropic funds carefully, to make sure they are directed to making a difference.” Gordon Mills, M.D., Ph,D., director of precision oncology at the OHSU Knight Cancer Institutes, describes the impact that philanthropy has on cancer science.
OHSU announced that internationally renowned scientist Gordon B. Mills, MD, PhD, has been recruited to lead precision oncology for the Knight Cancer Institute. Here are a few interesting facts about him.
Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks […]
Treatments for childhood cancers are harsh on kids’ bodies. While survival rates have improved dramatically over the last few decades, quality of life has not. Therapies such as chemotherapy and radiation can lead to learning disabilities, nerve damage, fertility issues and other health problems. OHSU cancer researchers are working to change that. Monika Davare, PhD, […]
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
